Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom

IMPORTANCE: Longer-term outcomes and risk factors associated with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) are not well established. OBJECTIVE: To investigate longer-term risk of relapse and factors associated with this risk among patients with MOGAD. DESIGN, SETTING,...

Descripción completa

Detalles Bibliográficos
Autores principales: Satukijchai, Chanjira, Mariano, Romina, Messina, Silvia, Sa, Mario, Woodhall, Mark R., Robertson, Neil P., Ming, Lim, Wassmer, Evangeline, Kneen, Rachel, Huda, Saif, Jacob, Anu, Blain, Camilla, Halfpenny, Christopher, Hemingway, Cheryl, O'Sullivan, Eoin, Hobart, Jeremy, Fisniku, Leonora K., Martin, Roswell, Dopson, Ruth, Cooper, Sarah A., Williams, Victoria, Waters, Patrick J., Ramdas, Sithara, Leite, Maria Isabel, Palace, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749481/
https://www.ncbi.nlm.nih.gov/pubmed/35006246
http://dx.doi.org/10.1001/jamanetworkopen.2021.42780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749481/
https://www.ncbi.nlm.nih.gov/pubmed/35006246
http://dx.doi.org/10.1001/jamanetworkopen.2021.42780

Ejemplares similares